Retrospective evaluation of transhepatic biliary stent placement in patients undergoing hepaticojejunostomy.

Objective: Cholecystectomy is one of the most common operations performed by surgeons all over the world. Bile duct injury (BDI) occurs in 0.2-0.6 % of cholecystectomies. Methodology: We aimed to investigate the effects of transhepatic transanastomotic stent use in patients who underwent Roux-en-Y hepaticojejunostomy due to iatrogenic bile duct injury. The study included 37 patients who underwent R&Y hepticojejunostomy anastomosis due to iatrogenic bile duct injury at the General Surgery Clinic of the Afyonkarahisar Health Sciences University Medical Faculty Hospital between January 2010 to July 2024. Results: A total of 37 hepaticojejunostomy patients were included in the study; 16 (%43.2) received transhepatic stent and 21 (%56.8) did not receive stent. No mortality occurred in any of the patients. It was observed that the rate of Bismuth Type-1 was statistically significantly higher in the group without stent placement and Bismuth Type-4 was statistically significantly higher in the group with stent placement (p<0.001). The mean timing time was 13.75±7.37 days in the group without stent placement and 4.00±3.30 days in the group with stent placement, which was significantly higher in the group without stent placement (p<0.001). No significant difference was observed between the groups in terms of complication development (p=0.933). Conclusions: As a result, although we prefer the use of transanastomotic stents in bile duct reconstruction after biliary injury in selected cases, we think that studies with larger series are needed.